Michael D. Axelson
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
-
- Genetic factors in colorectal cancer
Papers in
-
- Hedgehog Signaling Pathway Studies 1
- Oncology 3
- Colorectal Cancer Treatments and Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Cancer-related Molecular Pathways 1
- Co-authors
- Heinz‐Josef Lenz (2 shared papers)Michael A. Morse (2 shared papers)Rebecca A. Moss (2 shared papers)Joseph L. Leach (2 shared papers)Jayesh Desai (2 shared papers)Michael J. Overman (2 shared papers)Andrew Hill (2 shared papers)Monica V. Goldberg (2 shared papers)
- Journals
- Clinical Cancer Research (1 paper)Neoplasia (1 paper)Journal of Clinical Oncology (1 paper)Thrombosis and Haemostasis (1 paper)Clinical Breast Cancer (1 paper)
- Partner nations
- United StatesAustraliaItaly
In The Last Decade
Michael D. Axelson
6 papers receiving 2.2k citations
Michael D. Axelson's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 1.9k
- Pathology and Forensic Medicine 811
- Cancer Research 376
- Immunology 447
- Pulmonary and Respiratory Medicine 399
Countries citing papers authored by Michael D. Axelson
This map shows the geographic impact of Michael D. Axelson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Axelson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Axelson more than expected).
Fields of papers citing papers by Michael D. Axelson
This network shows the impact of papers produced by Michael D. Axelson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Axelson. The network helps show where Michael D. Axelson may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael D. Axelson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study Hit paper breakdown → | 2017 | 1977 |
| 2 | 2013 | 140 | |
| 3 | 2016 | 109 | |
| 4 | 2007 | 31 | |
| 5 | 2020 | 10 | |
| 6 | 1999 | 4 |
About Michael D. Axelson
Michael D. Axelson is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Pharmacology, having authored 6 papers that have together received 2.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (2 papers), Genetic factors in colorectal cancer (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer and Skin Lesions (1 paper), Cancer Genomics and Diagnostics (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Cancer-related Molecular Pathways (1 paper) and Hedgehog Signaling Pathway Studies (1 paper). The work is most often cited by research in Oncology (1.9k citations), Pathology and Forensic Medicine (811 citations), Cancer Research (376 citations), Immunology (447 citations) and Pulmonary and Respiratory Medicine (399 citations). Michael D. Axelson has collaborated with scholars based in United States, Australia and Italy. Frequent co-authors include Heinz‐Josef Lenz, Michael A. Morse, Rebecca A. Moss, Joseph L. Leach, Jayesh Desai, Michael J. Overman, Andrew Hill, Monica V. Goldberg, Thierry André and Ray McDermott. Their work appears in journals such as Clinical Cancer Research, Neoplasia, Journal of Clinical Oncology, Thrombosis and Haemostasis and Clinical Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.